Retinoblastoma Cell Biology
Research from Hiroshima University, Department of Neurosurgery in the area of retinoblastoma cell biology published
Published in Gene Therapy Weekly, June 21st, 2007
Current study results from the report, "Retinoblastoma protein prevents staurosporine-induced cell death in a retinoblastoma-defective human glioma cell line," have been published. In this recent report, researchers in Japan conducted a study "To investigate the mechanism of staurosporine-induced glioma cell death and cell cycle arrest using adenovirus-mediated gene transfection, as well as the function of retinoblastoma (Rb) and genetic instability induced by staurosporine. Cell cycle regulation, cell death and nuclear abnormalities induced by staurosporine were examined using an adenovirus vector expressing Rb, p16 or p21 genes in human glioma cell lines."
"The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-06-21)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Neuronal Activity Gives Clues to Working Memory - Gene Therapy
MUHC-led international team identifies gene responsible for blindness in infants and children - Gene Therapy
Novel Technologies Advance Gene Transfer Applications - Cancer Gene Therapy
Capsulution and QIAGEN begin Research Project on LBL-Capsules and Nano-Tests - Cancer Gene Therapy
Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting - Cancer Gene Therapy
Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
